Det anvendes hos patienter med Philadelphia- kromosompositiv (Ph+) leukæmi, hvilket betyder, at nogle af patientens gener har byttet plads for at danne et særligt kromosom, det såkaldte Philadelphiakromosom.
It is used when the patient is ‘ Philadelphia chromosome positive’ (Ph+), which means that some of the patient ’ s genes have re-arranged themselves to form a special chromosome called the Philadelphia chromosome.